Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Health Care Information Technology: Venture's New Darling?

This article was originally published in Start Up

Executive Summary

As traditional venture-like returns are harder to generate from drug development and medtech plays, some frustrated VCs see new opportunities in health care information technology, an area many have traditionally avoided.

Related Content

Good News, Bad News On Medication Adherence: Problem Understood, Now How To Fix Human Behavior?
Life Sciences VCs Leave Morgenthaler, ATV To Form New Fund
Biopharmaceuticals Beyond The Drug: Changing Pharma's Value Proposition
Pharma Plus: Merck’s Global Health Innovation Fund
Merck's Capital Idea: Industry's Latest Push to Strengthen VC Ties
START-UP's 2011 Life Science Venture Capital Survey: Biopharmaceutical Investors Let Some Sunshine In
Financings Of The Fortnight Tries To Beat The Summer Heat
Health IT Will Require Active Management To Achieve Health Care Improvements – Surescripts Exec
Wireless Apps and Cloud Computing: The Future of Health Care?
Proteus Biomedical: Using Computers to Manage Chronic Diseases


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts